We are live on ! Find out more
TCM

Traynor Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 62.36%
This Fund
S&P 500
This Quarter Est. Return
+1.18%
1 Year Est. Return
+62.36%
3 Year Est. Return
+225.14%
5 Year Est. Return
+309.6%
10 Year Est. Return
+1,325.66%
AUM
$120M
AUM Growth
+$15.6M
Cap. Flow
+$15.6M
Cap. Flow %
13.04%
Top 10 Hldgs %
46.75%
Holding
154
New
30
Increased
62
Reduced
44
Closed
13

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$2.65M
2
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$895K
3
PGP
PIMCO Global StockPLUS & Income Fund
PGP
+$827K
4
BIIB icon
Biogen
BIIB
+$795K
5
PFE icon
Pfizer
PFE
+$666K

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$605K
2
MTW icon
Manitowoc
MTW
+$406K
3
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$398K
4
AMD icon
Advanced Micro Devices
AMD
+$346K
5
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$334K

Sector Composition

Rank Sector Weight
1 Healthcare 15.26%
2 Technology 12.31%
3 Communication Services 5.77%
4 Industrials 3.81%
5 Energy 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TWTR
151
DELISTED
Twitter, Inc.
TWTR
– –
-5,414
Closed -$271K
SGYP
152
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
– –
-16,100
Closed -$74K
XCO
153
DELISTED
Exco Resources
XCO
– –
-2,267
Closed -$62K
WLT
154
DELISTED
WALTER ENERGY INC COM STK (DE)
WLT
– –
-10,000
Closed -$6K
3 4 5 6
7

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
SCP
Seizert Capital Partners Birmingham, Michigan $2.17B AUM 11.2% 1-Year Est. Return
CAG
Csenge Advisory Group Clearwater, Florida $2.18B AUM 16.73% 1-Year Est. Return
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
MMLI
Massachusetts Mutual Life Insurance Springfield, Massachusetts $2.17B AUM 48.68% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM

Traynor Capital Management's Q2 2015 Portfolio in Review

As of Q2 2015, Traynor Capital Management held 154 positions worth $120M, up 15% from $104M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Traynor Capital Management deployed $15.6M of net new capital in Q2 2015, opening 30 new positions and adding to 62 existing holdings. Its largest new stake was Biogen: 1,980 shares worth $799K.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, an estimated $398K trimmed.

  • Traynor Capital Management's largest Q2 2015 buy was Biogen: 1,980 shares worth $799K.
  • Traynor Capital Management added most to Novo Nordisk in Q2 2015, an estimated $2.65M increase.
  • Traynor Capital Management's biggest Q2 2015 reduction was iShares iBoxx $ Investment Grade Corporate Bond ETF, cutting an estimated $398K.
  • Traynor Capital Management fully exited Eli Lilly in Q2 2015, selling an estimated $605K.
  • Traynor Capital Management's ten largest holdings make up 47% of its $120M portfolio in Q2 2015.
  • Traynor Capital Management opened 30 new positions and closed 13 in Q2 2015.
  • Traynor Capital Management's portfolio value rose 15% quarter-over-quarter to $120M.

Based on Traynor Capital Management's 13F filing for Q2 2015, filed 23 Feb 2016.